Search clinical trials for: MRx0518
Total 15 results
-
Imperial College London4D pharma plcActive, not recruitingMelanoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Renal Cancer | Urethral Cancer | Uterine CancerUnited Kingdom
-
4D pharma plcTerminatedPancreatic CancerUnited States
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
4D pharma plcWithdrawnUrothelial CarcinomaUnited States
-
Leap Therapeutics, Inc.Completed
-
medac GmbHRecruitingSteroid-refractory Acute Graft-versus-host DiseaseSpain, Germany, France, Poland, Sweden
-
4D pharma plcMerck Sharp & Dohme LLCTerminatedMelanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | OncologyUnited States
-
Merck Sharp & Dohme LLCCompletedHIV Infections | Acquired Immunodeficiency Syndrome
-
medac GmbHRecruitingSteroid-refractory Acute Graft-versus-host DiseaseGermany, Spain, France, Poland
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCApproved for marketing
-
Canadian Immunodeficiency Research CollaborativeNational Institutes of Health (NIH)Completed
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
Merck Sharp & Dohme LLCCompletedHIV Infections | Acquired Immunodeficiency Syndrome
-
Merck Sharp & Dohme LLCCompleted